Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Surakala M"'
Autor:
Golubic R; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK., Kennet J; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Parker V; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Robertson D; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Luo D; Statistics, Biometrics Oncology, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hansen L; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Jermutus L; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ambery P; Late Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ryaboshapkina M; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Surakala M; R&D IT, AstraZeneca, Cambridge, UK., Laker RC; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Venables M; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK., Koulman A; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK., Park A; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Evans M; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2634-2644. Date of Electronic Publication: 2024 Apr 01.
Autor:
Harrod A; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK.; Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK., Lai CF; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK., Goldsbrough I; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK., Simmons GM; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK., Oppermans N; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK., Santos DB; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK., Győrffy B; Semmelweis University Department of Bioinformatics, H-1094 Budapest, Hungary and TTK Cancer Biomarker Research Group, H-1117, Budapest, Hungary., Allsopp RC; Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, LE2 7LX, UK., Toghill BJ; Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, LE2 7LX, UK., Balachandran K; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK., Lawson M; Early Oncology R&D, AstraZeneca, Biomedical Campus, 1 Francis Crick Ave, Cambridge, CB2 0AA, UK., Morrow CJ; Early Oncology R&D, AstraZeneca, Biomedical Campus, 1 Francis Crick Ave, Cambridge, CB2 0AA, UK., Surakala M; Early Oncology R&D, AstraZeneca, Biomedical Campus, 1 Francis Crick Ave, Cambridge, CB2 0AA, UK., Carnevalli LS; Early Oncology R&D, AstraZeneca, Biomedical Campus, 1 Francis Crick Ave, Cambridge, CB2 0AA, UK., Zhang P; Early Oncology R&D, AstraZeneca, Biomedical Campus, 1 Francis Crick Ave, Cambridge, CB2 0AA, UK., Guttery DS; Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, LE2 7LX, UK., Shaw JA; Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, LE2 7LX, UK., Coombes RC; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK., Buluwela L; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK. l.buluwela@imperial.ac.uk., Ali S; Department of Surgery & Cancer, Imperial College London, London, W12 0NN, UK. simak.ali@imperial.ac.uk.
Publikováno v:
Oncogene [Oncogene] 2022 Oct; Vol. 41 (44), pp. 4905-4915. Date of Electronic Publication: 2022 Oct 05.
Autor:
Kostrzewski T; CN Bio Innovations Ltd, Cambridge, UK. tomasz.kostrzewski@cn-bio.com., Snow S; CN Bio Innovations Ltd, Cambridge, UK., Battle AL; CN Bio Innovations Ltd, Cambridge, UK., Peel S; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Ahmad Z; Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Basak J; Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Surakala M; R&D IT, AstraZeneca, Chennai, India., Bornot A; Quantitative Biology and Data Science, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Lindgren J; Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Ryaboshapkina M; Translational Science and Experimental Medicine, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Clausen M; Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Lindén D; Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Division of Endocrinology, Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Maass C; Certara, Quantitative Systems Pharmacology Unit, Sheffield, UK.; esqLABS GmbH, Saterland, Germany., Young LM; CN Bio Innovations Ltd, Cambridge, UK., Corrigan A; Quantitative Biology and Data Science, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Ewart L; Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Hughes D; CN Bio Innovations Ltd, Cambridge, UK.
Publikováno v:
Communications biology [Commun Biol] 2021 Sep 15; Vol. 4 (1), pp. 1080. Date of Electronic Publication: 2021 Sep 15.
Autor:
Kueh MTW; UCD School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; Royal College of Surgeons in Ireland and University College Dublin Malaysia Campus, Malaysia., Chong MC; Royal College of Surgeons of Ireland, Dublin, Ireland., Miras AD; School of Medicine, Ulster University, UK., le Roux CW; Diabetes Complications Research Centre, University College Dublin, Ireland.
Publikováno v:
The Journal of physiology [J Physiol] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.
Autor:
Popova L; Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ, USA., Carabetta VJ; Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ, USA. carabetta@rowan.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2025; Vol. 2866, pp. 287-315.
Publikováno v:
Micromachines; Mar2022, Vol. 13 Issue 3, p428, 19p